• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tamoxifen as risk factor for carcinoma of corpus uteri.

作者信息

Hardell L

出版信息

Lancet. 1988 Sep 3;2(8610):563. doi: 10.1016/s0140-6736(88)92675-x.

DOI:10.1016/s0140-6736(88)92675-x
PMID:2900934
Abstract
摘要

相似文献

1
Tamoxifen as risk factor for carcinoma of corpus uteri.他莫昔芬作为子宫体癌的危险因素。
Lancet. 1988 Sep 3;2(8610):563. doi: 10.1016/s0140-6736(88)92675-x.
2
Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients.绝经后乳腺癌患者中与他莫昔芬相关的子宫内膜癌
Gynecol Oncol. 1990 Oct;39(1):82-4. doi: 10.1016/0090-8258(90)90404-9.
3
[Uterine pathology in women with breast cancer treated with tamoxifen].[接受他莫昔芬治疗的乳腺癌女性的子宫病理学]
Pathologica. 1997 Jun;89(3):223-33.
4
Tamoxifen-related uterine malignancies: carcinomas or sarcomas?他莫昔芬相关的子宫恶性肿瘤：癌还是肉瘤？
Int J Gynecol Cancer. 2004 Mar-Apr;14(2):395. doi: 10.1111/j.1048-891X.2004.014229.x.
5
[Increase in risk of endometrial carcinoma following treatment of breast carcinoma with tamoxifen].[他莫昔芬治疗乳腺癌后子宫内膜癌风险增加]
Ned Tijdschr Geneeskd. 1995 Nov 18;139(46):2393.
6
Four case reports presenting new acquisitions on the association between breast and endometrial carcinoma.四例病例报告展示了有关乳腺癌与子宫内膜癌关联的新发现。
Gynecol Oncol. 1990 Jun;37(3):378-80. doi: 10.1016/0090-8258(90)90371-q.
7
Endometrial carcinoma in five patients with breast cancer on tamoxifen therapy.5例接受他莫昔芬治疗的乳腺癌患者发生子宫内膜癌。
N Y State J Med. 1990 Apr;90(4):207-8.
8
Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients.绝经后乳腺癌患者中与他莫昔芬相关的子宫内膜癌
Gynecol Oncol. 1991 Jun;41(3):270. doi: 10.1016/0090-8258(91)90322-v.
9
Pelvic irradiation and tamoxifen as risk factors for carcinoma of corpus uteri.盆腔放疗和他莫昔芬作为子宫体癌的危险因素。
Lancet. 1988 Dec 17;2(8625):1432. doi: 10.1016/s0140-6736(88)90629-0.
10
[Uterine sarcoma associated with tamoxifen use after breast cancer: Review of the pathogenesis].[乳腺癌术后使用他莫昔芬相关的子宫肉瘤：发病机制综述]
J Gynecol Obstet Biol Reprod (Paris). 2009 Dec;38(8):629-33. doi: 10.1016/j.jgyn.2009.09.009. Epub 2009 Oct 14.

引用本文的文献

1
The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy.雌激素剥夺治疗后靶向雌激素受体的分子、细胞及临床后果。
Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3(0 3):245-63. doi: 10.1016/j.mce.2015.06.004. Epub 2015 Jun 5.
2
The evolution of nonsteroidal antiestrogens to become selective estrogen receptor modulators.非甾体类抗雌激素药物向选择性雌激素受体调节剂的演变。
Steroids. 2014 Nov;90:3-12. doi: 10.1016/j.steroids.2014.06.009. Epub 2014 Jun 17.
3
Proven value of translational research with appropriate animal models to advance breast cancer treatment and save lives: the tamoxifen tale.
利用合适的动物模型进行转化研究以推进乳腺癌治疗并挽救生命的已证实价值：他莫昔芬的故事。
Br J Clin Pharmacol. 2015 Feb;79(2):254-67. doi: 10.1111/bcp.12440.
4
Tamoxifen in breast cancer ipse dixit in uterine malignant mixed Müllerian tumor and sarcoma-A report of 8 cases and review of the literature.他莫昔芬在乳腺癌中的应用——子宫恶性苗勒管混合瘤和肉瘤病例报告（8例）及文献复习
Rep Pract Oncol Radiother. 2013 Aug 12;18(5):251-60. doi: 10.1016/j.rpor.2013.06.005.
5
The occurrence of invasive cancers following a diagnosis of breast carcinoma in situ.原位乳腺癌诊断后浸润性癌的发生情况。
Br J Cancer. 2008 Aug 19;99(4):611-5. doi: 10.1038/sj.bjc.6604524. Epub 2008 Jul 29.
6
Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.针对雌激素受体用于治疗和预防乳腺癌的疗法的发展与演变。
Steroids. 2007 Jan;72(1):7-25. doi: 10.1016/j.steroids.2006.10.009. Epub 2006 Dec 13.
7
Suppression of Estrogenic Activity by Medroxyprogesterone Acetate in Tamoxifen-treated Patients after Surgery for Breast Cancer to Reduce the Risk of Endometrial Cancer Development.
Breast Cancer. 1996 Mar 29;3(1):25-31. doi: 10.1007/BF02966959.
8
Gynecologic effects of tamoxifen: case reports and review of the literature.他莫昔芬的妇科效应：病例报告及文献综述
Int Urogynecol J Pelvic Floor Dysfunct. 1996;7(4):179-84. doi: 10.1007/BF01907069.
9
Gynaecologic effects of tamoxifen.他莫昔芬的妇科效应。
Med Oncol. 1995 Jun;12(2):87-94. doi: 10.1007/BF01676708.
10
A risk-benefit assessment of tamoxifen therapy.他莫昔芬治疗的风险效益评估。
Drug Saf. 1993 May;8(5):381-97. doi: 10.2165/00002018-199308050-00005.